High materiality7/10
Veracyte initiated with an Overweight at Piper Sandler
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler initiates Veracyte (VCYT) with Overweight; target $66 vs current price $56.62.
- Piper Sandler initiates Overweight; target $66; price $56.62
Key facts
- 01
Target: $66
- 02
Posted price: $56.62
- 03
Analyst firm: Piper Sandler
- 04
Analyst: David Westenberg
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.